FIVE vs MRNA · P/E 28, rev $1.39B vs rev $1.94B
Five Below Inc (FIVE) versus Moderna Inc (MRNA) — a side-by-side from cached financials, not a winner call.
Five Below Inc (FIVE) is a specialty retail company listed on US.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stephane Bancel.
Latest reported FIVE revenue for 2025-02-01 was $1.39B. Net income was $187.5M. Revenue was up 64.9% from 2024-11-02 to 2025-02-01. FIVE currently screens at market cap $7.30B and trailing P/E 27.7.
Latest reported MRNA revenue for 2025-12-31 was $1.94B. Net income was -$2.82B. Revenue was down 39.9% from 2024-12-31 to 2025-12-31. MRNA currently screens at market cap $24.52B.
FIVE currently screens at market cap $7.30B and trailing P/E 27.7. MRNA currently screens at market cap $24.52B.
Not investment advice. Open the FIVE and MRNA stock pages for the full models.
Not investment advice.